Successful management of drug-induced skin rash in a relapsed multiple myeloma patient with pomalidomide desensitization

DOI Web Site PubMed

Bibliographic Information

Other Title
  • Pomalidomideによる皮膚障害に対して脱感作療法が有効であった再発難治性多発性骨髄腫
  • Pomalidomide ニ ヨル ヒフ ショウガイ ニ タイシテ ダツカンサ リョウホウ ガ ユウコウ デ アッタ サイハツ ナンチセイ タハツセイ コツズイシュ

Search this article

Description

<p>A 71-year-old man diagnosed with IgG-κ type multiple myeloma 11 years ago was treated with low doses of pomalidomide (POM, 1 mg/daily) and dexamethasone (20 mg/week) as the third-line of salvage regimen. The treatment was terminated 4 days later owing to the appearance of a severe skin rash, which had also occurred after previous treatment with lenalidomide. After 2 months, POM was readministered via an outpatient desensitization protocol under prednisolone administration. During five cycles of POM-treatment, no severe skin rash appeared, and partial remission was obtained even though the final POM dose was as low as 1 mg/day.</p>

Journal

  • Rinsho Ketsueki

    Rinsho Ketsueki 60 (2), 137-139, 2019

    The Japanese Society of Hematology

Keywords

Details 詳細情報について

Report a problem

Back to top